The document announces the availability of a market research report on the Astrocytoma therapeutic pipeline from Global Markets Direct. The report provides an overview and details on drug candidates in development for Astrocytoma, including those from companies and universities. It covers products from discovery to registration stages and key players involved. Sample pages of the report can be requested by email.

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Astrocytoma – Pipeline Review, H2 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Astrocytoma - Pipeline Review, H2 2012, provides an
overview of the Astrocytoma therapeutic pipeline. This report provides information
on the therapeutic development for Astrocytoma, complete with latest updates, and
special features on late-stage and discontinued projects. It also reviews key players
involved in the therapeutic development for Astrocytoma. Astrocytoma - Pipeline
Review, H2 2012 is built using data and information sourced from Global Markets
Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Astrocytoma.
- A review of the Astrocytoma products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.

2. Table of contents:
List of Tables 8
List of Figures 11
Introduction 12
Global Markets Direct Report Coverage 12
Astrocytoma Overview 13
Therapeutics Development 14
An Overview of Pipeline Products for Astrocytoma 14
Astrocytoma Therapeutics under Development by Companies 16
Astrocytoma Therapeutics under Investigation by Universities/Institutes 23
Late Stage Products 31
Comparative Analysis 31
Mid Clinical Stage Products 32
Comparative Analysis 32
Early Clinical Stage Products 33
Comparative Analysis 33
Discovery and Pre-Clinical Stage Products 34
Comparative Analysis 34
Astrocytoma Therapeutics – Products under Development by Companies 35
Astrocytoma Therapeutics – Products under Investigation by Universities/Institutes
42
Companies Involved in Astrocytoma Therapeutics Development 58
F. Hoffmann-La Roche Ltd. 58
Amgen Inc. 59
Sanofi-Aventis 60
AstraZeneca PLC 61
Eli Lilly and Company 62
Genentech, Inc. 63
MedImmune LLC 64
Merck & Co., Inc. 65
Lentigen Corporation 66
Sangamo BioSciences, Inc. 67
Plexxikon Inc. 68

3. Celltrion, Inc. 69
Ark Therapeutics Group plc 70
Novartis AG 71
Actelion Ltd 72
Eisai Co., Ltd. 73
Nippon Shinyaku Co., Ltd. 74
Pfizer Inc. 75
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Astrocytoma – Pipeline Review, H2 2012
Autoimmune Disorders – Pipeline Review, H2 2012
HIV / AIDS – Pipeline Review, H2 2012
Contraceptives – Pipeline Review, H2 2012
Metastatic Prostate Cancer – Pipeline Review, H2 2012
Fungal Infections – Pipeline Review, H2 2012

4. Mycobacterium Infections – Pipeline Review, H2 2012
Brain Cancer – Pipeline Review, H2 2012
Metastatic Colorectal Cancer – Pipeline Review, H2 2012
Orthomyxoviridae Infections – Pipeline Review, H2 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com